Developer docs
API playgroundTry for free, no card

Search company profiles

spineart

Full company profile

uuid00006p2

Namestring
spineart
Legal namestring
Spineart SA
Websiteurl
spineart.com
Company typeenum
Private
Founded yearint
2005
Descriptiontext

Spineart SA is a Switzerland-based medical device company founded in 2005 that develops and sells a comprehensive portfolio of spinal implants, surgical instruments, and enabling technologies. The company serves hospitals and spine surgery centers across 50+ countries, distributing its products through a direct field sales force targeting spine surgeons and healthcare institutions.

The product portfolio spans five core solution areas: motion preservation (BAGUERA C cervical and BAGUERA L lumbar disc prostheses with 18 years of clinical follow-up on BAGUERA C), interbody fusion (cages built on the proprietary Ti-LIFE 3D-printed porous titanium platform, including SCARLET AC-T/AC-Ti/AL-T, JULIET Ti, and TRYPTIK Ti product lines), posterior fixation (the PERLA platform with PERLA, PERLA TL, and PERLA TL MIS systems), enabling technologies (trajectory guidance via Pytheas partnership and robotics/navigation via eCential Robotics partnership), and biologics (ßGEL synthetic bone substitute, MatrixCellect DBM, BIOBank allografts, and soft tissue repair products). The underlying Ti-LIFE Technology — a biomimetic 3D-printed porous titanium with 0.9mm pore diameter and 70-75% porosity — is a key technical differentiator, with over 196,000 Ti-LIFE cages implanted globally.

Spineart monetizes through direct hardware sales of sterile, barcoded implants to healthcare institutions, with no public pricing disclosed. The go-to-market relies on enterprise field sales and a high-touch surgeon education program that conducts 40 events per year engaging approximately 1,200 surgeons with a 97% satisfaction rate. Revenue is supplemented by ongoing facility expansion (new R&D and training center in Dallas, new factory near Geneva) and clinical development (two completed IDE studies for BAGUERA C). The company is privately held, has raised approximately $140M+ in cumulative funding across rounds in 2016, 2020, 2024, and 2025, and employs 251-500 people.

Short descriptiontext

Spineart is a Switzerland-based medical device company founded in 2005 that develops and sells spinal implants, surgical instruments, and enabling technologies (including motion-preserving disc prostheses and 3D-printed titanium fusion cages) to hospitals and spine surgery centers across 50+ countries via direct field sales.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersPlan-les-ouates, Switzerland
HQ citystring
Plan-les-ouates
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
spinal implant devices, interbody fusion cages, motion preservation prosthetics, posterior fixation systems, spine surgery biologics
Industry4 codes
1Spine Implants & Motion Preservation (Fusion/Disc/Interspinous)
CodeHLAHAEACPrimaryYes
2Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
CodeHLAHAEALPrimaryNo
33D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial)
CodeHLAHAEAJPrimaryNo
4Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT)
CodeHLAHADAGPrimaryNo
NAICS code2 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Surgical & Medical Instruments & Apparatus3841
Product category
Spinal Medical Devices (Spinal Implants and Surgical Devices)
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Spinal Implant and Surgical Device Sales
TypeHardware Sales
Description

Spineart generates revenue through the sale of proprietary spinal implants and surgical devices including motion preservation products (disc prostheses), interbody fusion cages, posterior fixation systems, enabling technologies, and biologics. All devices are packaged individually, sterilized via gamma irradiation, and barcoded for complete traceability.

spineart.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Spineart designs, manufactures, and sells a comprehensive portfolio of spinal implant and surgical devices covering motion preservation (cervical and lumbar disc prostheses), interbody fusion (cervical, anterior lumbar, lateral, and posterior cages), posterior fixation (occipito-cervico-thoracic and thoracolumbar pedicle screw systems), enabling technologies (trajectory guidance, robotics, navigation), and biologics (synthetic bone substitutes, DBM, allografts, collagen-based products). All devices are individually packaged, gamma-sterilized, and barcoded for complete traceability. The company reaches hospitals and spine surgery centers through direct field sales and a global education program.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 196,000+ Ti-LIFE cages implanted globally
+6 more records
Product overview1 text field

Spineart offers a comprehensive portfolio of patented, clinically validated medical devices for spine surgery. The portfolio includes motion preservation solutions (BAGUERA® C and BAGUERA® L disc prostheses), interbody fusion cages utilizing proprietary Ti-LIFE 3D-printed porous titanium technology (TRYPTIK®Ti, SCARLET® AC-T/AC-Ti, SCARLET® AL-T, JULIET®Ti LL/PO OL TL), posterior fixation systems via the PERLA® PLATFORM (PERLA® for occipito-cervico-thoracic, PERLA® TL and PERLA® TL MIS for thoracolumbar), and biologics including synthetic bone substitute (ßGEL®), human demineralized bone matrix (MatrixCellect®), allografts (BIOBank), and soft tissue regeneration products (KBIO® DURA, KOLLAGEN, GENTA-COLL®, GENTA-FOIL, Collabarrier®). All devices are sterile-packaged with bar code traceability.

Product and service22 records
1BAGUERA C Cervical Disc Prosthesis
2BAGUERA L Lumbar Disc Prosthesis
CategoryMotion Preservation
Description

Lumbar disc prosthesis providing controlled movement and stability to preserve lumbar mobility, with customizable motion control (mobile and fixed nucleus options), UHMWPE nucleus, and Diamond-Like-Carbon coating to reduce MRI artifacts. Available in 3 disc heights, 3 footprints, and 2 lordosis angles; for hospitals and spine surgeons performing lumbar disc replacement.

3TRYPTIK Ti Anterior Cervical Cage
CategoryInterbody Fusion
Description

Ti-LIFE anterior cervical cage available in anatomic or 7° lordotic shapes, with stabilizing fins to prevent rotation and migration, a large bone graft window, and low material density for optimal visualization of the fusion process. Indicated for ACDF procedures in hospitals and spine surgery centers.

4SCARLET AC-T Secured Cervical Cage
CategoryInterbody Fusion
Description

Secured anterior cervical cage with titanium construction, self-drilling screws, and a zero-profile design. Features an anatomical endplate fit, optional 7° lordosis, a large graft window, and titanium serrated surfaces for primary stability. Backed by 12 years of clinical experience and 28,000+ surgeries performed.

5SCARLET AC-Ti Secured Anterior Cervical Cage
CategoryInterbody Fusion
Description

Next-generation Ti-LIFE secured anterior cervical cage with a redefined anatomical shape derived from morphometric analysis, integrated screw guides (40° craniocaudal and 7.5° mediolateral angulation), and a zero-profile one-step locking mechanism with integrated cam locks. For spine surgeons and hospitals performing anterior cervical fusion.

6SCARLET AL-T Lumbar Anterior Cage
CategoryInterbody Fusion
Description

Ti-LIFE secured lumbar anterior cage with anatomical shape for optimal endplate fit, one-step cam lock mechanism, integrated screw channel, zero-profile design, and high-performance self-drilling screws. Available in three footprints with a hyperlordotic version; 25,000+ implants in 30+ countries.

7JULIET Ti LL Lateral Cage
CategoryInterbody Fusion
Description

Ti-LIFE lateral cage with anatomical shape, a low-profile integrated plate with a two-screw configuration, and MIS lateral approach compatibility using the OTELO LL retractor. Includes instruments with working lengths optimized for the lateral approach.

8JULIET Ti PO OL TL Posterior Cages
CategoryInterbody Fusion
Description

Ti-LIFE posterior cages for posterior, oblique, and transforaminal lumbar approaches, featuring a bullet-nosed tip for easy distraction, polished chamfer, large bone graft windows, and overall reduced density for optimal imaging. Available in a wide range of options for different patient anatomies; 65,000+ implants across 750+ centers in 40+ countries.

9TRYPTIK 2 C-PLATE Anterior Cervical Plate System
CategoryInterbody Fusion
Description

Anterior cervical plate system with an anti-backout system, one-step locking mechanism, pre-lordosed design for 1–4 levels, low profile for soft tissue protection, and compact streamlined instrumentation for ACDF procedures.

10PERLA Occipito-Cervico-Thoracic Fixation System
CategoryPosterior Fixation
Description

Occipito-cervico-thoracic fixation system with versatile screw selection (polyaxial, smooth shank, preferred angle), an adjustable occipital plate with 360° rotation, navigation-compatible instrumentation, and multiple transition options to PERLA TL. For complex posterior cervical and cervico-thoracic constructs.

11PERLA TL Thoracolumbar Fixation System
CategoryPosterior Fixation
Description

Thoracolumbar fixation system with a Dual Core screw design for variable thread depth, a 25D semipolyaxial screw for deformity correction, 45mm reduction capability, navigation compatibility, and dual rod diameter compatibility (5.5mm and 6mm). For thoracolumbar posterior fusion procedures.

12PERLA TL MIS Minimally Invasive Fixation System
CategoryPosterior Fixation
Description

MIS thoracolumbar fixation system with integrated tulips for narrower incisions, a micro-self-threading screw head, 20mm built-in reduction, and guided secure rod insertion. Dual core bone screw provides variable thread depth for better anatomical adaptation.

13Trajectory Guidance Solution (Pytheas collaboration)
CategoryEnabling Technologies
Description

Innovative mobile trajectory guidance solution combining mobility, precision, and exclusive sensing technology. Features 12 inertial measurement units, a tablet interface, and a compact case; tailored for PERLA posterior fixation systems to provide real-time trajectory control.

14Robotics and Navigation Platform (eCential Robotics collaboration)
CategoryEnabling Technologies
Description

Robotics and navigation platform combining robotic and navigation-guided screw placement with automatic registration, patient movement compensation, and a 7-degrees-of-freedom robotic arm. Screw planning is semi-automated and supports both automated and collaborative modes; fully compatible with the PERLA platform and multiple 3D imaging devices.

15ßGEL Synthetic Bone Substitute
CategoryBiologics
Description

Synthetic osteoconductive putty composed of ultra-pure beta-tricalcium phosphate (β-TCP) fine granules in a biocompatible hydrogel carrier, with 75% overall porosity for cell-mediated resorption and bony integration, temperature-responsive stiffening, and ready-to-use syringe delivery. Used as a bone graft substitute in spine surgery.

16MatrixCellect 100 DBM
CategoryBiologics
Description

100% human demineralized bone matrix product line in putty and crunch formats. Processed with BIORISE technology to preserve bone morphogenetic proteins (BMPs) and growth factors for osteoinduction. The Crunch variant includes mineralized cancellous bone chips for additional osteoconductive structure. Used as a bone graft in spine fusion.

17BIOBank Allografts
CategoryBiologics
Description

Freeze-dried bone allografts from human femoral heads obtained during hip arthroplasty, processed using Supercrit technology with supercritical CO2 to eliminate adipocytes and cellular debris while achieving viral inactivation and preserving bone matrix and structural integrity.

18KBIO DURA Dural Substitute Matrix
CategoryBiologics / Soft Tissue Repair
Description

Bovine Type I collagen dural substitute matrix, fully biocompatible and resorbable. Features a porous sponge layer adapting to neural tissue irregularities and a smooth collagen layer preventing cerebrospinal fluid leakage; applied onlay without sutures.

19KOLLAGEN resorb Hemostatic Sponge
CategoryBiologics / Soft Tissue Repair
Description

Equine Type I collagen resorbable hemostatic sponge indicated as an adjunct for intraoperative hemostatic control, with high compatibility, efficient fluid absorption, and easy handling in clean surgical procedures.

20GENTA-COLL resorb Antibiotic Collagen Sponge
CategoryBiologics / Soft Tissue Repair
Description

Equine Type I collagen hemostatic sponge impregnated with gentamicin (2mg/cm²) for local hemostasis and antibacterial prophylaxis, providing controlled antibiotic release with high local therapeutic concentrations and minimal systemic exposure.

21GENTA-FOIL resorb Antibiotic Collagen Sheet
CategoryBiologics / Soft Tissue Repair
Description

Equine Type I collagen sheet impregnated with gentamicin (4mg/cm²) serving as a resorbable anti-adhesion barrier and antibiotic delivery vehicle, preventing postoperative tissue adhesions while providing local antibacterial protection.

22Collabarrier Adhesion Prevention Gel
CategoryBiologics / Soft Tissue Repair
Description

Porcine Type I collagen resorbable gel designed to prevent postoperative adhesions. High viscosity enables effective coverage of exposed tissues, forming a temporary barrier during the healing process.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeTechnology or Integration
Description

Strategic partnership with eCential Robotics to provide advanced robotics and navigation platform technology. The platform combines robotic and navigation-guided screw placement with automatic registration, patient movement compensation, and a 7-degrees-of-freedom robotic arm. Fully compatible with PERLA PLATFORM and multiple 3D imaging devices.

Strategic tierCoreTypeTechnology or Integration
Description

Collaboration with Pytheas to develop a trajectory guidance solution combining mobility, precision, and exclusive sensing technology. The solution features 12 inertial measurement technology tailored specifically for PERLA posterior fixation systems, operates via tablet interface, and fits into a small case for mobility.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Globus Medical (now combined with NuVasive) is one of the largest spine-focused medical device companies with a broad motion preservation, interbody, fixation, and enabling-tech (ExcelsiusGPS robotics) portfolio. Directly comparable as a spine-specialist competing across all of Spineart's product segments.

TypeBroad incumbent
Description

Medtronic's Spine division is the global market leader with CD Horizon, Prestige LP cervical disc, and Mazor robotic-assisted spine surgery platform. Broad incumbent offering overlapping across all of Spineart's segments with much larger commercial reach.

TypeBroad incumbent
Description

Stryker's Spine division (including legacy Wright Medical and Mesa Mako integration) offers interbody cages, fixation systems, and the Mako robotic platform. Direct competitor in spine hardware and enabling technologies.

TypeDirect peer
Description

ZimVie (spun off from Zimmer Biomet) is a focused spine company offering Mobi-C cervical disc, interbody fusion systems (Zyston, Alberso), and posterior fixation. Closely comparable as a mid-sized spine-specialist with cervical disc focus similar to BAGUERA C.

TypeDirect peer
Description

ATEC is a US-based pure-play spine company focused on procedurally integrated solutions, with a growing portfolio of interbody cages, fixation systems, and the EOS imaging platform. Directly comparable as a mid-sized spine competitor with surgeon-relationship-driven GTM.

TypeDirect peer
Description

Pre-merger NuVasive was a major spine specialist with the Pulse robotics/navigation platform, XLIF lateral approach, and cervical disc portfolio. Closely comparable in motion preservation (disc replacement) and enabling technologies strategy.

TypeDirect peer
Description

Orthofix offers spine hardware (M6 cervical disc, interbody cages, fixation) along with biologics and bone growth stimulation. Comparable mid-sized peer with cervical disc and biologics presence similar to Spineart's BAGUERA and biologics lines.

TypeBroad incumbent
Description

Aesculap (B. Braun division) offers a comprehensive spine portfolio including activL lumbar disc, S4 cervical disc, interbody fusion, and fixation systems. Comparable as a broader medtech incumbent with full spine portfolio similar to Spineart.

TypeEmerging player
Description

Brainlab provides surgical navigation, planning, and mixed reality for spine and neurosurgery, including the Loop-X imaging and Curve navigation platforms. Comparable in the enabling-technology segment where Spineart partners with eCential Robotics and Pytheas.

TypeEmerging player
Description

SI-BONE is a focused spine company pioneering sacroiliac joint fusion (iFuse). Adjacent comparison as a smaller, focused spine company targeting specific indications with surgeon-relationship-driven commercial model similar to Spineart.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

spineart

Spinal Medical Devices (Spinal Implants and Surgical Devices)spineart.com

Spineart is a Switzerland-based medical device company founded in 2005 that develops and sells spinal implants, surgical instruments, and enabling technologies (including motion-preserving disc prostheses and 3D-printed titanium fusion cages) to hospitals and spine surgery centers across 50+ countries via direct field sales.

What spineart does

Spineart SA is a Switzerland-based medical device company founded in 2005 that develops and sells a comprehensive portfolio of spinal implants, surgical instruments, and enabling technologies. The company serves hospitals and spine surgery centers across 50+ countries, distributing its products through a direct field sales force targeting spine surgeons and healthcare institutions.

The product portfolio spans five core solution areas: motion preservation (BAGUERA C cervical and BAGUERA L lumbar disc prostheses with 18 years of clinical follow-up on BAGUERA C), interbody fusion (cages built on the proprietary Ti-LIFE 3D-printed porous titanium platform, including SCARLET AC-T/AC-Ti/AL-T, JULIET Ti, and TRYPTIK Ti product lines), posterior fixation (the PERLA platform with PERLA, PERLA TL, and PERLA TL MIS systems), enabling technologies (trajectory guidance via Pytheas partnership and robotics/navigation via eCential Robotics partnership), and biologics (ßGEL synthetic bone substitute, MatrixCellect DBM, BIOBank allografts, and soft tissue repair products). The underlying Ti-LIFE Technology — a biomimetic 3D-printed porous titanium with 0.9mm pore diameter and 70-75% porosity — is a key technical differentiator, with over 196,000 Ti-LIFE cages implanted globally.

Spineart monetizes through direct hardware sales of sterile, barcoded implants to healthcare institutions, with no public pricing disclosed. The go-to-market relies on enterprise field sales and a high-touch surgeon education program that conducts 40 events per year engaging approximately 1,200 surgeons with a 97% satisfaction rate. Revenue is supplemented by ongoing facility expansion (new R&D and training center in Dallas, new factory near Geneva) and clinical development (two completed IDE studies for BAGUERA C). The company is privately held, has raised approximately $140M+ in cumulative funding across rounds in 2016, 2020, 2024, and 2025, and employs 251-500 people.

spineart firmographics

Firmographics
Name
spineart
Legal name
Spineart SA
Website
https://spineart.com
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
251–500 employees
Short description
Spineart is a Switzerland-based medical device company founded in 2005 that develops and sells spinal implants, surgical instruments, and enabling technologies (including motion-preserving disc prostheses and 3D-printed titanium fusion cages) to hospitals and spine surgery centers across 50+ countries via direct field sales.
Ownership category
akta.pro rank

spineart industry classification

Industry
Product category
Spinal Medical Devices (Spinal Implants and Surgical Devices)
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Spine Implants & Motion Preservation (Fusion/Disc/Interspinous) (HLAHAEAC)
akta.pro secondary industries
Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL), 3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial) (HLAHAEAJ), Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT) (HLAHADAG)

Keywords

  • Spinal implant devices
  • Interbody fusion cages
  • Motion preservation prosthetics
  • Posterior fixation systems
  • Spine surgery biologics

Where spineart is headquartered

Location

Headquarters

HQ city
Plan-les-ouates
HQ country
Switzerland
HQ region
Europe

Offices2 records

Markets served

spineart business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

  1. Spinal Implant and Surgical Device Sales: Spineart generates revenue through the sale of proprietary spinal implants and surgical devices including motion preservation products (disc prostheses), interbody fusion cages, posterior fixation systems, enabling technologies, and biologics. All devices are packaged individually, sterilized via gamma irradiation, and barcoded for complete traceability.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

spineart product offering

Product offering

Core offering

Spineart designs, manufactures, and sells a comprehensive portfolio of spinal implant and surgical devices covering motion preservation (cervical and lumbar disc prostheses), interbody fusion (cervical, anterior lumbar, lateral, and posterior cages), posterior fixation (occipito-cervico-thoracic and thoracolumbar pedicle screw systems), enabling technologies (trajectory guidance, robotics, navigation), and biologics (synthetic bone substitutes, DBM, allografts, collagen-based products). All devices are individually packaged, gamma-sterilized, and barcoded for complete traceability. The company reaches hospitals and spine surgery centers through direct field sales and a global education program.

Product overview

Spineart offers a comprehensive portfolio of patented, clinically validated medical devices for spine surgery. The portfolio includes motion preservation solutions (BAGUERA® C and BAGUERA® L disc prostheses), interbody fusion cages utilizing proprietary Ti-LIFE 3D-printed porous titanium technology (TRYPTIK®Ti, SCARLET® AC-T/AC-Ti, SCARLET® AL-T, JULIET®Ti LL/PO OL TL), posterior fixation systems via the PERLA® PLATFORM (PERLA® for occipito-cervico-thoracic, PERLA® TL and PERLA® TL MIS for thoracolumbar), and biologics including synthetic bone substitute (ßGEL®), human demineralized bone matrix (MatrixCellect®), allografts (BIOBank), and soft tissue regeneration products (KBIO® DURA, KOLLAGEN, GENTA-COLL®, GENTA-FOIL, Collabarrier®). All devices are sterile-packaged with bar code traceability.

Differentiator

Problem solved

Functional benefit

Products and services

  • BAGUERA C Cervical Disc Prosthesis
  • BAGUERA L Lumbar Disc Prosthesis Lumbar disc prosthesis providing controlled movement and stability to preserve lumbar mobility, with customizable motion control (mobile and fixed nucleus options), UHMWPE nucleus, and Diamond-Like-Carbon coating to reduce MRI artifacts. Available in 3 disc heights, 3 footprints, and 2 lordosis angles; for hospitals and spine surgeons performing lumbar disc replacement.
  • TRYPTIK Ti Anterior Cervical Cage Ti-LIFE anterior cervical cage available in anatomic or 7° lordotic shapes, with stabilizing fins to prevent rotation and migration, a large bone graft window, and low material density for optimal visualization of the fusion process. Indicated for ACDF procedures in hospitals and spine surgery centers.
  • SCARLET AC-T Secured Cervical Cage Secured anterior cervical cage with titanium construction, self-drilling screws, and a zero-profile design. Features an anatomical endplate fit, optional 7° lordosis, a large graft window, and titanium serrated surfaces for primary stability. Backed by 12 years of clinical experience and 28,000+ surgeries performed.
  • SCARLET AC-Ti Secured Anterior Cervical Cage Next-generation Ti-LIFE secured anterior cervical cage with a redefined anatomical shape derived from morphometric analysis, integrated screw guides (40° craniocaudal and 7.5° mediolateral angulation), and a zero-profile one-step locking mechanism with integrated cam locks. For spine surgeons and hospitals performing anterior cervical fusion.
  • SCARLET AL-T Lumbar Anterior Cage Ti-LIFE secured lumbar anterior cage with anatomical shape for optimal endplate fit, one-step cam lock mechanism, integrated screw channel, zero-profile design, and high-performance self-drilling screws. Available in three footprints with a hyperlordotic version; 25,000+ implants in 30+ countries.
  • JULIET Ti LL Lateral Cage Ti-LIFE lateral cage with anatomical shape, a low-profile integrated plate with a two-screw configuration, and MIS lateral approach compatibility using the OTELO LL retractor. Includes instruments with working lengths optimized for the lateral approach.
  • JULIET Ti PO OL TL Posterior Cages Ti-LIFE posterior cages for posterior, oblique, and transforaminal lumbar approaches, featuring a bullet-nosed tip for easy distraction, polished chamfer, large bone graft windows, and overall reduced density for optimal imaging. Available in a wide range of options for different patient anatomies; 65,000+ implants across 750+ centers in 40+ countries.
  • TRYPTIK 2 C-PLATE Anterior Cervical Plate System Anterior cervical plate system with an anti-backout system, one-step locking mechanism, pre-lordosed design for 1–4 levels, low profile for soft tissue protection, and compact streamlined instrumentation for ACDF procedures.
  • PERLA Occipito-Cervico-Thoracic Fixation System Occipito-cervico-thoracic fixation system with versatile screw selection (polyaxial, smooth shank, preferred angle), an adjustable occipital plate with 360° rotation, navigation-compatible instrumentation, and multiple transition options to PERLA TL. For complex posterior cervical and cervico-thoracic constructs.
  • PERLA TL Thoracolumbar Fixation System Thoracolumbar fixation system with a Dual Core screw design for variable thread depth, a 25D semipolyaxial screw for deformity correction, 45mm reduction capability, navigation compatibility, and dual rod diameter compatibility (5.5mm and 6mm). For thoracolumbar posterior fusion procedures.
  • PERLA TL MIS Minimally Invasive Fixation System MIS thoracolumbar fixation system with integrated tulips for narrower incisions, a micro-self-threading screw head, 20mm built-in reduction, and guided secure rod insertion. Dual core bone screw provides variable thread depth for better anatomical adaptation.
  • Trajectory Guidance Solution (Pytheas collaboration) Innovative mobile trajectory guidance solution combining mobility, precision, and exclusive sensing technology. Features 12 inertial measurement units, a tablet interface, and a compact case; tailored for PERLA posterior fixation systems to provide real-time trajectory control.
  • Robotics and Navigation Platform (eCential Robotics collaboration) Robotics and navigation platform combining robotic and navigation-guided screw placement with automatic registration, patient movement compensation, and a 7-degrees-of-freedom robotic arm. Screw planning is semi-automated and supports both automated and collaborative modes; fully compatible with the PERLA platform and multiple 3D imaging devices.
  • ßGEL Synthetic Bone Substitute Synthetic osteoconductive putty composed of ultra-pure beta-tricalcium phosphate (β-TCP) fine granules in a biocompatible hydrogel carrier, with 75% overall porosity for cell-mediated resorption and bony integration, temperature-responsive stiffening, and ready-to-use syringe delivery. Used as a bone graft substitute in spine surgery.
  • MatrixCellect 100 DBM 100% human demineralized bone matrix product line in putty and crunch formats. Processed with BIORISE technology to preserve bone morphogenetic proteins (BMPs) and growth factors for osteoinduction. The Crunch variant includes mineralized cancellous bone chips for additional osteoconductive structure. Used as a bone graft in spine fusion.
  • BIOBank Allografts Freeze-dried bone allografts from human femoral heads obtained during hip arthroplasty, processed using Supercrit technology with supercritical CO2 to eliminate adipocytes and cellular debris while achieving viral inactivation and preserving bone matrix and structural integrity.
  • KBIO DURA Dural Substitute Matrix Bovine Type I collagen dural substitute matrix, fully biocompatible and resorbable. Features a porous sponge layer adapting to neural tissue irregularities and a smooth collagen layer preventing cerebrospinal fluid leakage; applied onlay without sutures.
  • KOLLAGEN resorb Hemostatic Sponge Equine Type I collagen resorbable hemostatic sponge indicated as an adjunct for intraoperative hemostatic control, with high compatibility, efficient fluid absorption, and easy handling in clean surgical procedures.
  • GENTA-COLL resorb Antibiotic Collagen Sponge Equine Type I collagen hemostatic sponge impregnated with gentamicin (2mg/cm²) for local hemostasis and antibacterial prophylaxis, providing controlled antibiotic release with high local therapeutic concentrations and minimal systemic exposure.
  • GENTA-FOIL resorb Antibiotic Collagen Sheet Equine Type I collagen sheet impregnated with gentamicin (4mg/cm²) serving as a resorbable anti-adhesion barrier and antibiotic delivery vehicle, preventing postoperative tissue adhesions while providing local antibacterial protection.
  • Collabarrier Adhesion Prevention Gel Porcine Type I collagen resorbable gel designed to prevent postoperative adhesions. High viscosity enables effective coverage of exposed tissues, forming a temporary barrier during the healing process.

Quantifiable outcome

  • 196,000+ Ti-LIFE cages implanted globally
  • +6 more outcomes

Companies that use spineart

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles1 record

spineart technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

Feature5 records

spineart partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • eCential RoboticscoreTechnology or IntegrationStrategic partnership with eCential Robotics to provide advanced robotics and navigation platform technology. The platform combines robotic and navigation-guided screw placement with automatic registration, patient movement compensation, and a 7-degrees-of-freedom robotic arm. Fully compatible with PERLA PLATFORM and multiple 3D imaging devices.
  • PytheascoreTechnology or IntegrationCollaboration with Pytheas to develop a trajectory guidance solution combining mobility, precision, and exclusive sensing technology. The solution features 12 inertial measurement technology tailored specifically for PERLA posterior fixation systems, operates via tablet interface, and fits into a small case for mobility.

Scale indicators8 records

Recent moves9 records

Expansion highlights4 records

spineart competitors and assessment

Company assessment

Direct peers

  • Globus Medical: Globus Medical (now combined with NuVasive) is one of the largest spine-focused medical device companies with a broad motion preservation, interbody, fixation, and enabling-tech (ExcelsiusGPS robotics) portfolio. Directly comparable as a spine-specialist competing across all of Spineart's product segments.
  • ZimVie Spine: ZimVie (spun off from Zimmer Biomet) is a focused spine company offering Mobi-C cervical disc, interbody fusion systems (Zyston, Alberso), and posterior fixation. Closely comparable as a mid-sized spine-specialist with cervical disc focus similar to BAGUERA C.
  • Alphatec Holdings (ATEC): ATEC is a US-based pure-play spine company focused on procedurally integrated solutions, with a growing portfolio of interbody cages, fixation systems, and the EOS imaging platform. Directly comparable as a mid-sized spine competitor with surgeon-relationship-driven GTM.
  • NuVasive (now part of Globus): Pre-merger NuVasive was a major spine specialist with the Pulse robotics/navigation platform, XLIF lateral approach, and cervical disc portfolio. Closely comparable in motion preservation (disc replacement) and enabling technologies strategy.
  • Orthofix Medical: Orthofix offers spine hardware (M6 cervical disc, interbody cages, fixation) along with biologics and bone growth stimulation. Comparable mid-sized peer with cervical disc and biologics presence similar to Spineart's BAGUERA and biologics lines.

Broad incumbents

  • Medtronic Spine: Medtronic's Spine division is the global market leader with CD Horizon, Prestige LP cervical disc, and Mazor robotic-assisted spine surgery platform. Broad incumbent offering overlapping across all of Spineart's segments with much larger commercial reach.
  • Stryker Spine: Stryker's Spine division (including legacy Wright Medical and Mesa Mako integration) offers interbody cages, fixation systems, and the Mako robotic platform. Direct competitor in spine hardware and enabling technologies.
  • B. Braun / Aesculap Spine: Aesculap (B. Braun division) offers a comprehensive spine portfolio including activL lumbar disc, S4 cervical disc, interbody fusion, and fixation systems. Comparable as a broader medtech incumbent with full spine portfolio similar to Spineart.

Emerging players

  • Brainlab: Brainlab provides surgical navigation, planning, and mixed reality for spine and neurosurgery, including the Loop-X imaging and Curve navigation platforms. Comparable in the enabling-technology segment where Spineart partners with eCential Robotics and Pytheas.
  • SI-BONE: SI-BONE is a focused spine company pioneering sacroiliac joint fusion (iFuse). Adjacent comparison as a smaller, focused spine company targeting specific indications with surgeon-relationship-driven commercial model similar to Spineart.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

spineart social profiles

Digital presence

spineart compliance and trust

Trust signal

Compliance1 record

spineart financial estimates

Financial estimate

Revenue estimate

Valuation estimate

spineart leadership team

Management profile

Number of profiles

Profiles6 records

spineart funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

spineart M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about spineart

What does spineart do?

Spineart designs, manufactures, and sells a comprehensive portfolio of spinal implant and surgical devices covering motion preservation (cervical and lumbar disc prostheses), interbody fusion (cervical, anterior lumbar, lateral, and posterior cages), posterior fixation (occipito-cervico-thoracic and thoracolumbar pedicle screw systems), enabling technologies (trajectory guidance, robotics, navigation), and biologics (synthetic bone substitutes, DBM, allografts, collagen-based products). All devices are individually packaged, gamma-sterilized, and barcoded for complete traceability. The company reaches hospitals and spine surgery centers through direct field sales and a global education program.

Is spineart a public or private company?

spineart is a private company. It is classified as venture growth investor backed and is currently operating.

When was spineart founded?

spineart was founded in 2005. It employs 251 to 500 people.

Where is spineart based?

spineart is headquartered in Plan-les-ouates, Switzerland, in the Europe region.

How does spineart make money?

One revenue line is on record: spinal Implant and Surgical Device Sales.

Who are spineart's main competitors?

Direct peers on record are Globus Medical, ZimVie Spine, Alphatec Holdings (ATEC), NuVasive (now part of Globus) and Orthofix Medical. Broad incumbents are Medtronic Spine, Stryker Spine and B. Braun / Aesculap Spine. Emerging players are Brainlab and SI-BONE.

Does spineart have an API?

No public API is recorded for spineart.

What industry is spineart in?

spineart's product category is Spinal Medical Devices (Spinal Implants and Surgical Devices). Its primary akta.pro industry code is HLAHAEAC, Spine Implants & Motion Preservation (Fusion/Disc/Interspinous), with a secondary code of HLAHAEAL, Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine). Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BioAlpsSpineart and eCential Robotics receive FDA clearance for the PERLA® TL applicationSpineart and eCential Robotics received FDA 510(k) clearance for the PERLA TL application to use with the eCential Op.n navigation and robotic-assisted platform. The clearance extends the solution to robotic-assisted workflows, enabling integrated navigation and robotics for implant placement accuracy in spine procedures.Unite.AISpineart’s PERLA TL App Gains FDA Clearance for Robotic Spine SurgerySpineart and eCential Robotics received FDA 510(k) clearance on August 26, 2026 for the PERLA TL app to run on eCential's Op.n robotic navigation platform, extending a prior navigation-only pairing into robotic-assisted workflows. The clearance covers the PERLA TL Open and MIS pedicle screw systems in open and minimally invasive procedures. The companies have been co-developing applications since a 2022 partnership announcement.PR NewswireSpineart and eCential Robotics receive FDA 510(k) clearance for the PERLA® TL application for use with eCential® Op.n® navigation system for robotic procedures.Spineart and eCential Robotics announced on August 26, 2026 that the FDA granted 510(k) clearance for the PERLA TL application for use with the eCential Op.n navigation and robotic-assisted platform. The clearance extends the previously compatible PERLA app to robotic-assisted workflows, supporting implant placement accuracy in open and minimally invasive spine procedures. The app will be displayed at Spineart's Innovation Center in Dallas, Texas.BioAlpsSpineart Announces FDA Approval ofBAGUERA® C Cervical DiscSpineart announced FDA approval of its BAGUERA C cervical disc for 1 and 2 contiguous levels. The device has sold over 80,000 units worldwide, with trials of nearly 600 U.S. patients and a 10-year study showing 85% motion preservation.startupticker.chTwo medtechs advance with regulatory approvalsSpineart received FDA approval for its cervical disc replacement system, expanding access to a motion-preserving surgical option in the United States. Simultaneously, Distalmotion obtained FDA clearance for its DEXTER robotic surgery system to perform ventral hernia repairs, completing its core outpatient portfolio.PR NewswireSpineart Announces FDA Approval of BAGUERA® C Cervical DiscSpineart announced FDA approval of its BAGUERA C cervical disc for 1-2 contiguous levels, expanding access to a motion-preserving solution for cervical disc disease. The approval is supported by two U.S. randomized controlled trials with nearly 600 patients, and over 80,000 devices have been sold worldwide.startupticker.chSpineart secures CHF 25M investment to boost global growthGeneva-based medtech company Spineart announced a CHF 25 million capital increase backed by existing investors Gimv and EGS Beteiligungen, representing a major milestone in the company's profitable growth journey. The funding will support innovation pipeline advancement, global expansion across Europe and the U.S., and manufacturing capabilities, with the company projecting revenues of approximately EUR 140 million in 2025. Spineart employs over 360 professionals worldwide and has achieved five consecutive years of growth at an average annual rate of 16%, with ongoing FDA submissions for its BAGUERA C cervical disc.WebdisclosureSpineart Secures CHF 25 Million to Boost Global GrowthGimv and EGS Beteiligungen have announced a CHF 25 million capital injection into Spineart to support its global expansion. The funding will foster Spineart's innovation pipeline and enhance its worldwide presence, particularly as it expands across Europe and the US with ongoing FDA submissions for its BAGUERA® C cervical disc prosthesis.NkfGimv and EGS Beteiligungen reinforce strategic support for SpineArt with CHF 25m capital increase to accelerate global growthSpineArt, a medtech company specializing in advanced spine surgery solutions, has raised CHF 25 million in a capital increase supported by its existing investors Gimv and EGS Beteiligungen. The funding will accelerate the company's profitable growth strategy, advance its innovation pipeline, and support global expansion including ongoing FDA submissions for the BAGUERA C cervical disc prosthesis in the United States. The company projects revenues of approximately EUR 140 million in 2025, reflecting five consecutive years of 16% annual growth.PR NewswireSPINEART ANNOUNCES FULL-MARKET LAUNCH OF SCARLET® AC-Ti SECURED ANTERIOR CERVICAL CAGE IN THE USSpineart announced the full-market launch of its SCARLET AC-Ti secured anterior cervical cage in the US, following 510(k) clearance in May 2024. The cage uses Ti-LIFE technology with a porous titanium structure and integrated screw guides. The company aims to make the technology available to more surgeons.